Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab
Garcia-Guerrero E, Gogishvili T, Danhof S, Schreder M, Pallaud C, Perez-Simon JA, Einsele H, Hudecek M (2017)
Publication Type: Journal article
Publication year: 2017
Journal
Book Volume: 129
Pages Range: 3386-3388
Journal Issue: 25
DOI: 10.1182/blood-2017-03-770776
Involved external institutions
Universitätsklinikum Würzburg
Germany (DE)
Novartis AG
Switzerland (CH)
University of Seville / Universidad de Sevilla
Spain (ES)
Germany (DE)
Novartis AG
Switzerland (CH)
University of Seville / Universidad de Sevilla
Spain (ES)
How to cite
APA:
Garcia-Guerrero, E., Gogishvili, T., Danhof, S., Schreder, M., Pallaud, C., Perez-Simon, J.A.,... Hudecek, M. (2017). Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab. Blood, 129(25), 3386-3388. https://doi.org/10.1182/blood-2017-03-770776
MLA:
Garcia-Guerrero, Estefania, et al. "Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab." Blood 129.25 (2017): 3386-3388.
BibTeX: Download